References
- Machover D, Goldschmidt E, Chollet P et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high dose folinic acid. J Clin Oncol 1986; 4: 685–696.
- Petrelli N, Douglass HD, Herrera L et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III study. J Clin Oncol 1989; 7: 1419–1426.
- Labianca R, Pancera G, Beretta G et al. A randomized study of intravenous fluorouracil plus or minus folinic acid in advanced metastatic colorectal carcinoma (AMC). Proc Am Soc Clin Oncol 1989; 8: 457.
- Nobile MT, Vidili GM, Sobreto A et al. 5-fluorouracil (FU) alone or combined with high dose folinic acid (FA) in advanced colorectal cancer patients: a randomized trial. Proc Am Soc Clin Oncol 1989; 9: 97.
- Richard F, Muss HB, Cooper R et al. Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum. Cancer 1979; 43: 91–96.
- Miller AB, Hoodgstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214.
- Carter SK. Large bowel cancer: the current status of treatment. J Natl Cancer Inst 1976; 56: 3–10.
- Moertel CG. Chemotherapy of gastrointestinal cancer. N Engl J Med 1978; 229: 1049–1052.
- Zorzitto ML, Myers R, Bazos MJ, Sheperd FA, Evans WK. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy. Am J Clin Oncol 1986; 9: 27–30.
- Cedermark BJ, Didolkar MS, Elias EG. Methyl-CCNU in advanced colorectal carcinoma after failure of 5-fluorouracil therapy. Cancer Treat Rep 1976; 60: 235–238.
- Engstrom PF, Maclntyre JM, Douglass HO, Muggia F, Mittelman A. Combination chemotherapy containing semustine in patients with advanced colorectal cancer previously treated with 5-fluorouracil. Am J Clin Oncol 1983; 6: 175–180.
- Vogl SE, Lanham R, Kaplan BH. Combination chemotherapy of advanced colorectal cancer with triazinate and ICFR-159 after failure of 5-fluorouracil. Oncology 1980; 37: 314–315.
- Barni S, Lissoni P, Paolorossi F, Crispino S, Archili C, Tancini G. A study of the pineal hormone melatonin as a second line therapy in metastatic colorectal cancer resistant to 5-fluorouracil plus folates. Tumori 1990; 76: 58–60.
- Marsh JC, Ganpule SR, Durivage H, Davis C, Sarris A, Handschumacher RE, Makuch R. Phase study of cyclosporin as second line therapy in metastatic colorectal cancer. Proc Am Assoc Cancer Res 1989; 30: A1023.
- Ahlgren JD, Trocki O, Gullo JJ, Muir Wa, Sisk R, Schachter L. Protracted infusion of 5FU with weekly low dose cisplatin as second line chemotherapy in patients with metastatic colorectal cancer who have failed 5FU monotherapy. Cancer Invest 1991; 9: 27–33.
- Kaplan H, Rivkin S. 5-fluorouracil and leucovorin in the treatment of metastatic colon carcinoma. Proc Am Soc Clin Oncol 1983; 2: 21.
- Van Groeningen CJ, Peters GJ, Pinedo HM. Lack of effectiveness of combined 5-fluorouracil and leucovorin in patients with 5-fluorouracil resistant advanced colorectal cancer. Eur J Cancer Clin Oncol 1989; 25: 45–49.
- Palmieri G, Gridelli C, Airoma G, Pepe R, Incoronato P, Capogiro F, Bianco AR. Second line chemotherapy of advanced colorectal cancer with sequential high dose methotrexate and 5-fluorouracil. J Chemother 1991; 3: 55–60.
- Wadler S, Schwartz EL, Goldman M et al. Fluorouracil and recombinant alpha 2a interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol 1989- 7–1769-1775.
- Murphy WK, Burgess MA, Gottlieb JA et al. Methyl-CCNU and methotrexate in 5-FU refractory tumors Proc Am Soc Clin Oncol 1976; 17: 269.